Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: Symposium Mammographicum 2006

Audit of wide bore needle biopsies graded B3: does the final pathology justify the increasing rate of benign biopsy?

NR Wakeham, K Satchithananda and NK Barrett

Breast Cancer Research 2006, 8(Suppl 1):P9 doi:10.1186/bcr1424

Accesses  

  • Last 30 days: 44 accesses
  • Last 365 days: 290 accesses
  • All time: 1748 accesses